Home Cart 0 Sign in  
X

[ CAS No. 1019387-69-9 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1019387-69-9
Chemical Structure| 1019387-69-9
Chemical Structure| 1019387-69-9
Structure of 1019387-69-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 1019387-69-9 ]

Related Doc. of [ 1019387-69-9 ]

Alternatived Products of [ 1019387-69-9 ]

Product Details of [ 1019387-69-9 ]

CAS No. :1019387-69-9 MDL No. :MFCD11131977
Formula : C10H14N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :ZJWDUXSEAHEJED-UHFFFAOYSA-N
M.W :194.23 Pubchem ID :28399982
Synonyms :

Calculated chemistry of [ 1019387-69-9 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.4
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 54.96
TPSA : 62.22 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.29 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.73
Log Po/w (XLOGP3) : 1.68
Log Po/w (WLOGP) : 1.8
Log Po/w (MLOGP) : 0.0
Log Po/w (SILICOS-IT) : 1.1
Consensus Log Po/w : 1.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.85

Water Solubility

Log S (ESOL) : -2.22
Solubility : 1.17 mg/ml ; 0.006 mol/l
Class : Soluble
Log S (Ali) : -2.6
Solubility : 0.487 mg/ml ; 0.00251 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.66
Solubility : 0.421 mg/ml ; 0.00217 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.81

Safety of [ 1019387-69-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312+P330-P302+P352+P312-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P363-P403+P233-P405-P501 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1019387-69-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1019387-69-9 ]

[ 1019387-69-9 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 1215264-39-3 ]
  • [ 1019387-69-9 ]
  • [ 2429965-72-8 ]
YieldReaction ConditionsOperation in experiment
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.166667h; 5.5.1 Example 5.1 (General Route) N-[(3S)-1-[6-(tert-Butylamino)pyridine-3-carbonyl]pyrrolidin-3-yl]-N-methylacetamideN-[(3S)-1-[6-(tert-Butylamino)pyridine-3-carbonyl]pyrrolidin-3-yl]-N-methylacetamide To a mixture of 2.20 g (11.4 mmol) 6-(tert-Butylamino)pyridine-3-carboxylic acid (example I), 2.43 g (13.6 mmol) N-Methyl-N-[(3S)-pyrrolidin-3-yl]acetamide hydrochloride (example VI) and 7.85 mL (45.4 mmol) DIPEA in 20 mL DMF are added 3.83 g (11.9 mmol) TBTU and the reaction mixture is stirred at RT for 10 min. The solvent is partially removed in vacuo and the remaining mixture is purified by HPLC (ACN/H2O/NH4OH). (0450) C17H26N4O2 (M=318.4 g/mol) (0451) ESI-MS: 319 [M+H]+ (0452) Rt (HPLC): 0.64 min (method B)
Same Skeleton Products
Historical Records